Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Double Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01003236
What this trial is testing

Evaluating the Renoprotective Effect of Milk Thistle Extract on Patients With Type II Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Shiraz University of Medical Sciences 60
Not applicableEnded earlyNCT06572839
What this trial is testing

Amnio-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone

Who this might be right for
Diabetic Foot Ulcer
Capsicure, LLC 74
Testing effectiveness (Phase 2)Looking for participantsNCT06897475
What this trial is testing

LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 200
Not applicableUnknownNCT01951859
What this trial is testing

Effects of a Homeopathic Anti-inflammatory Topical Cream on Ulcers and Neuropathy in the Diabetic Foot

Who this might be right for
Diabetic Neuropathy
Calvary Hospital, Bronx, NY 15
Large-scale testing (Phase 3)Study completedNCT00447382
What this trial is testing

Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 330
Early research (Phase 1)Study completedNCT02079870
What this trial is testing

Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With Placebo

Who this might be right for
DiabetesMetabolism and Nutrition DisorderObesity
Novo Nordisk A/S 30
Large-scale testing (Phase 3)Study completedNCT01529541
What this trial is testing

Efficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin Alone

Who this might be right for
Type 2 Diabetes Mellitus
JW Pharmaceutical 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT05687890
What this trial is testing

Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease

Who this might be right for
Diabetic Kidney DiseaseIgA Nephropathy
Biocity Biopharmaceutics Co., Ltd. 255
Early research (Phase 1)Study completedNCT00625859
What this trial is testing

Assess the Safety of Repeated Doses of GSK189075 and WELLBUTRIN SR in Healthy Male Subjects

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 27
Testing effectiveness (Phase 2)Study completedNCT05623189
What this trial is testing

HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Type 2 Diabetes
HighTide Therapeutics (Hong Kong) Limited 218
Not applicableStudy completedNCT05890690
What this trial is testing

Plasma Copeptin in Response to Oral Urea in Healthy Adults and Patients With Polyuria-polydipsia Syndrome

Who this might be right for
Arginine Vasopressin DeficiencyPrimary Polydipsia
University Hospital, Basel, Switzerland 48
Large-scale testing (Phase 3)Study completedNCT04537923
What this trial is testing

Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 1,428
Testing effectiveness (Phase 2)Study completedNCT03126786
What this trial is testing

Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Clearside Biomedical, Inc. 71
Large-scale testing (Phase 3)Study completedNCT02229383
What this trial is testing

Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
AstraZeneca 464
Testing effectiveness (Phase 2)Study completedNCT00157482
What this trial is testing

Ezetimibe and Simvastatin in Dyslipidemia of Diabetes

Who this might be right for
Type 2 Diabetes
Mario Negri Institute for Pharmacological Research 108
Not applicableStudy completedNCT02023320
What this trial is testing

Effects of Blueberry Dry Powder on Glycemic Status in Subjects With Prediabetes

Who this might be right for
Prediabetes
Hiroshima University 50
Not applicableUnknownNCT04073927
What this trial is testing

Effect of Butyrate on Inflammation and Albuminuria in Patients With Albuminuria, Type 1 Diabetes and Intestinal Inflammation

Who this might be right for
Diabetes Mellitus, Type 1Albuminuria
Steno Diabetes Center Copenhagen 48
Early research (Phase 1)Study completedNCT01464099
What this trial is testing

Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 24
Testing effectiveness (Phase 2)WithdrawnNCT05937152
What this trial is testing

CGRP Monoclonal Antibody to Treat Diabetic Neuropathy

Who this might be right for
Diabetic Polyneuropathy
Mayo Clinic
Large-scale testing (Phase 3)Study completedNCT00616811
What this trial is testing

Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency

Who this might be right for
Diabetes Mellitus, Type 2
Novartis 148
Next Page